αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
This is a single arm, open-label, dose escalation clinical study to evaluate the safety and tolerability of autologous mesothelin (MSLN)-targeted chimeric antigen receptor (MSLN-CAR) T cells secreting PD-1 nanobodies (αPD1-MSLN-CAR T cells) in patients with solid tumors.
创建时间：
2020-03-15
